Plus, rheumatology drug news, safety updates
Search results for: herpes zoster
Janus Kinase Inhibitors Represent New Tool to Slow Rheumatoid Arthritis
Physicians at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco report on studies about JAK inhibitors as targeted immunomodulators and disease-modifying therapies in RA
7 Things Ophthalmologists Want Rheumatologists to Know
Careful collaboration is key to treating patients with rheumatic or inflammatory diseases that affect the eyes
Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis
Small molecule kinase inhibitors, such as JAK inhibitors, provide a novel route for rheumatic disease treatment—and may promote our understanding of the immune system’s complexities
ACR Winter Rheumatology Symposium: New Kinase Inhibitors Show Promise
Toxicity and appropriate targeting are challenges for small molecule researchers
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Why Oral Corticosteroids Should Not be Used in Patients with Rheumatoid Arthritis
Steroid use in patients with rheumatoid arthritis (RA) has been linked to higher mortality rates, greater rate of infections, more cases of pneumonia, and serious gastrointestinal events
ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
People with rheumatic diseases can be considered to receive flu and pneumococcal vaccines even if they’re on immunosuppressive drugs
As Population Ages, Rheumatologists Prepare to Treat Elderly Patients with More Comorbidities
Cardiovascular disease, diabetes are among the conditions that add another layer of complexity in treating older rheumatology patients
Drug Updates: Lorcaserin, Acetaminophen, and More
information on new approvals and medication safety
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- Next Page »